Form 4 Tracker
Mansoor Raza Mirza

Chief Medical Officer; Director · 3 filings · Latest: Jul 10, 2026

Acrivon Therapeutics, Inc.
SERA PROGNOSTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SERA
Mirza Mansoor Raza—Dec 5, 2025
Proposed Sale
$3.05292$892—
SERA
Mirza Mansoor Raza—Nov 5, 2025
Proposed Sale
$3.04221$672—
SERA
Mirza Mansoor Raza—Oct 6, 2025
Proposed Sale
$3.16227$718—
SERA
Mirza Mansoor Raza—Sep 5, 2025
Proposed Sale
$3.35222$744—
SERA
Mirza Mansoor Raza—Aug 5, 2025
Proposed Sale
$2.50225$563—
SERA
Mirza Mansoor Raza—Jul 7, 2025
Proposed Sale
$2.36234$552—
SERA
Mirza Mansoor Raza—Jun 6, 2025
Proposed Sale
$1.58107$169—
SERA
Mirza Mansoor Raza—May 8, 2025
Proposed Sale
$2.44106$259—
SERA
Mirza Mansoor Raza—Apr 7, 2025
Proposed Sale
$3.35107$358—
SERA
Mirza Mansoor Raza—Mar 6, 2025
Proposed Sale
$4.1699$412—
SERA
Mirza Mansoor Raza—Feb 12, 2025
Proposed Sale
$4.57101$462—
SERA
Mirza Mansoor Raza—Jan 6, 2025
Proposed Sale
$7.59100$759—
SERA
Mirza Mansoor Raza—Dec 6, 2024
Proposed Sale
$7.1293$662—
SERA
Mirza Mansoor Raza—Nov 11, 2024
Proposed Sale
$7.2695$690—
SERA
Mirza Mansoor Raza—Oct 7, 2024
Proposed Sale
$7.0496$676—
SERA
Mirza Mansoor Raza—Sep 6, 2024
Proposed Sale
$7.0596$677—